Competitive APIs

GMP Approved Cyclosporine 59865-13-3 (Ciclosporin)

Cyclosporin A 59865-13-3 Cyclosporine

Cyclosporine was first marketed as Neoral in 1995 by Novartis in Canada, but it was first discovered in 1970 by Sandoz.

Cyclosporine, AKA Ciclosporin / Cyclosprorin A etc, is a cyclic undecapeptide from an extract of soil fungi. It is a powerful immunosupressant with a specific action on T-lymphocytes. It is used for the prophylaxis of graft rejection in organ and tissue transplantation. 

Cyclosporine is a natural cyclic polypeptide immunosuppressant isolated from the fungus Beauveria nivea. The exact mechanism of action of cyclosporine is not known but may involve binding to the cellular protein cytophilin, resulting in inhibition of the enzyme calcineurin. This agent appears to specifically and reversibly inhibit immunocompetent lymphocytes in the G0-or G1-phase of the cell cycle. T-lymphocytes are preferentially inhibited with T-helper cells as the primary target. Cyclosporine also inhibits lymphokine production and release. 

Chemical Facts of Cyclosporine 59865-13-3 (Cyclosporin A)
Appearance:white powder
Cas No:59865-13-3
Molecular Weight:1202.84
Melting Point:1293.8 °C
Boiling Point: 595 °C
Flash Point: 736.3 °C

Synonyms of Cyclosporine: 
Ciclosporin, Ciclosporina, Ciclosporine, Ciclosporinum, CsA, CyA, Cyclosporin, Cyclosporin A, Cyclosporine.

Documents available for Cyclosporine (Ciclosporin): GMP/DMF/COA/MSDS